Disease Trajectories in the Revised Hammersmith Scale in a Cohort of Untreated Patients with Spinal Muscular Atrophy types 2 and 3
Journal of Neuromuscular Diseases · 2024
DOI: 10.3233/jnd-230211 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuromuscular Diseases, 2024. Verfasst von Amy Wolfe und 34 weiteren Autor:innen. Beteiligte Einrichtung: Dubowitz Neuromuscular Centre, UCL Great Ormond Street Institute of Child Health, London, UK. Hauptthemen laut MEDLINE: Spinal Muscular Atrophies of Childhood. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Spinal muscular atrophy (SMA) is a neuromuscular disorder characterised by progressive motor function decline. Motor function is assessed using several functional outcome measures including the Revised Hammersmith Scale (RHS).
Objective
In this study, we present longitudinal trajectories for the RHS in an international cohort of 149 untreated paediatric SMA 2 and 3 patients (across 531 assessments collected between March 2015 and July 2019).
Methods
We contextualise these trajectories using both the Hammersmith Functional Motor Scale Expanded (HFMSE) and Revised Upper Limb Module (RULM). At baseline, this cohort included 50% females and 15% of patients had undergone spinal fusion surgery. Patient trajectories were modelled using a natural cubic spline with age, sex, and random effects for each patient.
Results
RHS and HFMSE scores show similar trends over time in this cohort not receiving disease modifying therapies. The results confirm the strong correlation between the RHS and RULM previously observed in SMA types 2 and 3a. Scoliosis surgery is associated with a reduction of 3 points in the RHS, 4.5 points in the HFMSE for the SMA 2 population, and a reduction of 11.8 points in the RHS, and 13.4 points in the HFMSE for the SMA 3a populations. When comparing the RHS and RULM, there is a lower correlation in the type 3a’s than the type 2 patients. In the SMA 2 population, there is no significant difference between the sexes in either the RHS or HFMSE trajectories. There is no significant difference in the RULM trajectory in the SMA 2 or 3a participants by sex.
Conclusions
This study demonstrates that the RHS could be used in conjunction with other functional measures such as the RULM to holistically detect SMA disease progression. This will assist with fully understanding changes that occur with treatments, further defining trajectories and therapy outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dubowitz Neuromuscular Centre, UCL Great Ormond Street Institute of Child Health, London, UK.
- Evelina London Children's Hospital, Guys and St Thomas' NHS Foundation Trust, London, UK.
- National Institute for Health Research Great Ormond Street Hospital Biomedical Research Centre, London, UK.
- University of Suffolk, Ipswich, UK.
- Pediatric Neurology Unit, Catholic University, Rome, Italy.
- Centro Clinico Nemo, U.O.C. Neuropsichiatria Infantile Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Zitieren
APA
Wolfe, A., Stimpson, G., Ramsey, D., Coratti, G., Dunaway Young, S., Mayhew, A., Pane, M., Rohwer, A., Muni Lofra, R., Duong, T., O'Reilly, E., Milev, E., Civitello, M., Sansone, V. A., D'Amico, A., Bertini, E., Messina, S., Bruno, C., Albamonte, E., …, & international SMA consortium (iSMAc) (2024). Disease Trajectories in the Revised Hammersmith Scale in a Cohort of Untreated Patients with Spinal Muscular Atrophy types 2 and 3. Journal of Neuromuscular Diseases. https://doi.org/10.3233/jnd-230211
Vancouver
Wolfe A, Stimpson G, Ramsey D, Coratti G, Dunaway Young S, Mayhew A, et al. Disease Trajectories in the Revised Hammersmith Scale in a Cohort of Untreated Patients with Spinal Muscular Atrophy types 2 and 3. Journal of Neuromuscular Diseases. 2024. doi:10.3233/jnd-230211
BibTeX
@article{Wolfe2024,
author = {Wolfe, Amy and Stimpson, Georgia and Ramsey, Danielle and Coratti, Giorgia and Dunaway Young, Sally and Mayhew, Anna and Pane, Marika and Rohwer, Annemarie and Muni Lofra, Robert and Duong, Tina and O'Reilly, Emer and Milev, Evelin and Civitello, Matthew and Sansone, Valeria A and D'Amico, Adele and Bertini, Enrico and Messina, Sonia and Bruno, Claudio and Albamonte, Emilio and Mazzone, Elena and Main, Marion and Montes, Jacqueline and Glanzman, Allan M and Zolkipli-Cunningham, Zarazuela and Pasternak, Amy and Marini-Bettolo, Chiara and Day, John W and Darras, Basil T and De Vivo, Darryl C and Baranello, Giovanni and Scoto, Mariacristina and Finkel, Richard S and Mercuri, Eugenio and Muntoni, Francesco and international SMA consortium (iSMAc), international SMA consortium (iSMAc)},
title = {Disease Trajectories in the Revised Hammersmith Scale in a Cohort of Untreated Patients with Spinal Muscular Atrophy types 2 and 3},
journal = {Journal of Neuromuscular Diseases},
year = {2024},
doi = {10.3233/jnd-230211}
}
EUVIMED